Review Article

Association of the Three Common SNPs of Cyclooxygenase-2 Gene (rs20417, rs689466, and rs5275) with the Susceptibility of Breast Cancer: An Updated Meta-Analysis Involving 34,590 Subjects

Table 3

Meta-analysis of the association between COX-2 polymorphisms and breast cancer risk.

ComparisonsOR95% CI valueHeterogeneityEffects model
value

B versus A
 rs204171.040.98–1.100.1756%0.06R
  Caucasian1.020.96–1.080.500%0.92F
  Asian1.451.15–1.840.0020%0.47F
 rs6894660.990.94–1.040.6933%0.21F
  Caucasian0.970.92–1.030.340%0.58F
  Asian1.140.97–1.33
 rs52751.010.98–1.050.5056%0.01R
  Caucasian1.000.97–1.040.8041%0.09R
  Asian1.030.89–1.190.700%0.51F
BB versus AA
 rs204171.211.02–1.420.030%0.97F
  Caucasian1.201.02–1.420.030%0.92F
  Asian1.540.49–4.780.460%0.68F
 rs6894661.010.88–1.150.9322%0.28F
  Caucasian0.950.82–1.100.520%0.69F
  Asian1.310.95–1.80
 rs52751.040.96–1.120.3466%0.0008R
  Caucasian1.010.94–1.100.7258%0.01R
  Asian1.260.85–1.850.257%0.30F
AB versus AA
 rs204170.970.91–1.030.3593%<0.00001R
  Caucasian0.940.88–1.010.0795%<0.00001R
  Asian1.491.15–1.910.0020%0.53F
 rs6894660.980.92–1.050.590%0.59F
  Caucasian0.970.91–1.040.440%0.74F
  Asian1.160.87–1.54
 rs52750.990.95–1.040.810%0.56F
  Caucasian0.990.95–1.040.810%0.47F
  Asian0.960.80–1.140.960%0.78F
AB + BB versus AA
 rs204171.010.96–1.080.6454%0.05R
  Caucasian1.000.93–1.060.930%0.84F
  Asian1.491.16–1.910.0020%0.49F
 rs6894660.900.87–0.950.000594%<0.00001R
  Caucasian0.880.83–0.94<0.000196%<0.00001R
  Asian1.210.92–1.58
 rs52751.020.98–1.070.3362%0.002R
  Caucasian1.020.97–1.070.4266%0.002R
  Asian0.990.84–1.170.920%0.86F
BB versus AA + AB
 rs204171.221.03–1.430.020%0.98F
  Caucasian1.211.03–1.430.020%0.94F
  Asian1460.47–4.560.510%0.70F
 rs6894661.010.89–1.150.850%0.48F
  Caucasian0.960.83–1.110.590%0.76F
  Asian1.180.92–1.51
 rs52751.040.97–1.120.2765%0.0009R
  Caucasian1.020.95–1.100.6060%0.01R
  Asian1.280.87–1.870.2115%0.28F

A: represents the major allele; B: represents the minor allele; F: fixed-effects model; R: random-effects model.